Literature DB >> 16507413

Natural killer cells in breast cancer cell growth and metastasis in SCID mice.

Md Z Dewan1, H Terunuma, S Ahmed, K Ohba, M Takada, Y Tanaka, M Toi, N Yamamoto.   

Abstract

Natural killer (NK) cell is an important component of the innate immune system and plays a central role in host defense against tumor and virus-infected cells. This review briefly summarizes the role of murine NK cells in tumor growth and metastasis of breast cancer cells in severe combined immunodeficiency (SCID) mice. Conventional SCID and NOD-SCID strains have been used to study for xenotransplantion of human tumors. SCID mice models of cancer mimic human diseases and have provided valuable information. However, these mice strains have some residual immunity such as NK cells that somewhat limit post-transplantation growth and metastasis of human xenografts. In contrast, NOD/SCID/gammac(null) (NOG) mice without common gamma-chain inoculated with breast cancer cells were most efficient in the formation of a large tumor and metastasis. NOG mouse strain without NK activity appears to be more promising as tool for xenotransplantion of human cancer. This new xenotransplant model is relevant and can be recommended for use in clarifying the mechanism of growth of cancer cells as well as for developing new therapeutic strategies against cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16507413     DOI: 10.1016/s0753-3322(05)80082-4

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  22 in total

1.  A novel animal model for bone metastasis in human lung cancer.

Authors:  Mi Li; Mingliang Zhou; Meng Gong; Junrong Ma; Fuxing Pei; Wesley G Beamer; Leonard D Shultz; Janet M Hock; Xijie Yu
Journal:  Oncol Lett       Date:  2012-02-01       Impact factor: 2.967

Review 2.  The immune system and inflammation in breast cancer.

Authors:  Xinguo Jiang; David J Shapiro
Journal:  Mol Cell Endocrinol       Date:  2013-06-19       Impact factor: 4.102

3.  Exploitation of herpesvirus immune evasion strategies to modify the immunogenicity of human mesenchymal stem cell transplants.

Authors:  Anabel S de la Garza-Rodea; Marieke C Verweij; Hester Boersma; Ietje van der Velde-van Dijke; Antoine A F de Vries; Rob C Hoeben; Dirk W van Bekkum; Emmanuel J H J Wiertz; Shoshan Knaän-Shanzer
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

4.  VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression.

Authors:  Joshua C Doloff; David J Waxman
Journal:  Cancer Res       Date:  2012-01-11       Impact factor: 12.701

5.  Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

Authors:  Emilie Mamessier; Aude Sylvain; Marie-Laure Thibult; Gilles Houvenaeghel; Jocelyne Jacquemier; Rémy Castellano; Anthony Gonçalves; Pascale André; François Romagné; Gilles Thibault; Patrice Viens; Daniel Birnbaum; François Bertucci; Alessandro Moretta; Daniel Olive
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

6.  Cyclic adenosine monophosphate differentiated beta-endorphin neurons promote immune function and prevent prostate cancer growth.

Authors:  Dipak K Sarkar; Nadka I Boyadjieva; Cui Ping Chen; María Ortigüela; Kenneth Reuhl; E Michael Clement; Peter Kuhn; Jason Marano
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-17       Impact factor: 11.205

7.  Beta-endorphin neuronal cell transplant reduces corticotropin releasing hormone hyperresponse to lipopolysaccharide and eliminates natural killer cell functional deficiencies in fetal alcohol exposed rats.

Authors:  Nadka I Boyadjieva; María Ortigüela; Alvaro Arjona; Xiaodong Cheng; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2009-03-11       Impact factor: 3.455

Review 8.  Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Authors:  Lacey E Dobrolecki; Susie D Airhart; Denis G Alferez; Samuel Aparicio; Fariba Behbod; Mohamed Bentires-Alj; Cathrin Brisken; Carol J Bult; Shirong Cai; Robert B Clarke; Heidi Dowst; Matthew J Ellis; Eva Gonzalez-Suarez; Richard D Iggo; Peter Kabos; Shunqiang Li; Geoffrey J Lindeman; Elisabetta Marangoni; Aaron McCoy; Funda Meric-Bernstam; Helen Piwnica-Worms; Marie-France Poupon; Jorge Reis-Filho; Carol A Sartorius; Valentina Scabia; George Sflomos; Yizheng Tu; François Vaillant; Jane E Visvader; Alana Welm; Max S Wicha; Michael T Lewis
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

9.  Comparing the MRI appearance of the lymph nodes and spleen in wild-type and immuno-deficient mouse strains.

Authors:  Vasiliki Economopoulos; Jennifer C Noad; Shruti Krishnamoorthy; Brian K Rutt; Paula J Foster
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

10.  An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2(-/-) gammac (-/-) mouse.

Authors:  Sylvia E Le Dévédec; Wies van Roosmalen; Naomi Maria; Max Grimbergen; Chantal Pont; Reshma Lalai; Bob van de Water
Journal:  Clin Exp Metastasis       Date:  2009-05-24       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.